Questcor Pharmacueticals (QCOR) Tops Q3 EPS by 20c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Ladenburg Thalmann Upgrades Questcor Pharmaceuticals (QCOR) to Buy
October 24, 2012 9:16 AM EDTLadenburg Thalmann upgraded Questcor Pharmaceuticals (NASDAQ: QCOR) from Neutral to Buy following Q3 results.
For an analyst ratings summary and ratings history on Questcor Pharmaceuticals click here. For more ratings news on Questcor Pharmaceuticals click here.
Shares of Questcor Pharmaceuticals closed at $25.93 yesterday, with a 52 week range of $17.25-$58.91.... More
Leerink Trims Valuation Range on Questcor (QCOR); Still Sees Broader Acthar Risk
October 24, 2012 7:51 AM EDTQuestcor Pharmaceutical (Nasdaq: QCOR) shares are higher amid a solid third-quarter report issued Tuesday night. However, one firm still sees some risk ahead.
Leerink Swann said it is keeping a Market Perform rating, but has adjusted its valuation range from $34 to $36 per share... More
